Identification and characterization of cancer stem cells and methods of use
AssigneeCity of Hope
InventorsMargarita Gutova, Chu-Chih Shih, Anna Gevorgyan, Karen Aboody, Josip Najbauer
Life of this patent
Estimating the term…
Abstract
A subpopulation of cancer stem cells expressing elevated levels of uPAR have been identified among a population of cancer cells. Methods are provided for treating proliferative disorders such as cancer by administering one or more uPAR inhibitors. Methods are likewise provided for predicting the likelihood of recurrence of a cancer, preventing recurrence of a cancer, and identifying the likelihood of a cancer to respond to a particular cancer therapy.
Claims3
An in vitro small cell lung cancer (SCLC) cell population comprising more than 5% uPAR positive cancer stem cells, wherein the uPAR positive cancer stem cells are additionally selected from the group consisting of CD44 positive cancer stem cells, MDR positive cancer stem cells, tumorigenic cancer stem cells, and metastatic cancer stem cells.
Dependencies are inferred from the claim text.